PathogenDx, Inc.

SCOTTSDALE, AZ · Founded 2015 · CIK 0001669428 · Medtech · Private

Rapid pathogen detection and identification platform for cannabis, food, and life sciences samples

pathogendx.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$675K
1 Form D · Apr 2016
126 months since last filing
Contracts
—
No federal contracts on record
Patents
11
0 granted · 11 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$675,000
Form D · SEC

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1075ResQ Pharma, Inc.—$2.4M
1076ZSX MEDICAL LLC—$1.1M
1077Reflexion Pharmaceuticals, Inc.—$1.1M
1078PathogenDx, Inc.—$675K
1079DANAHER CORP /DE/—$13M
1080Vira Regen Inc.—$3.0M
1081CRESCEL LLC—$1.4M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 3 related persons
  • Michael HoganDirector · Executive Officer
  • Eric LachanceDirector · Executive Officer
  • Milan PatelDirector · Executive Officer

Patents

USPTO · 0 granted of 11
  • Methods for Detecting and Discriminating among Microbes in Microbial Pathogen Mixturesapplication
  • Transcription Mediated Amplification Methods for RNA Detectionapplication
  • Methods for Salmonella Serovar Analysis and Differentiationapplication
  • Methods For Salmonella Serovar Analysis And Differentiationapplication
  • Transcription Mediated Amplification Methods For Rna Detectionapplication
  • Combinatorial Microarray Assay For Clade Variant Detectionapplication
  • Methods For Detecting Airborne Viruses In Air Samplesapplication
  • Methods For Detecting Low Levels Of COVID-19 Virusapplication
  • Methods For Detecting Low Levels Of COVID-19 Virusapplication
  • Methods For Microbial Dna Analysisapplication
  • Microarray Based Multiplex Pathogen Analysis And Uses Thereofapplication

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.